ReportWire

Tag: Health Care

  • State of the Union 2026: Fact-checks of Democrats’ responses

    [ad_1]

    In a move that reflected the party’s divisions, Democrats offered a range of responses to President Donald Trump’s Feb. 24 State of the Union address. 

    Some skipped Trump’s speech or attended alternate events. Others spoke out in opposition to Trump’s words.

    Virginia Gov. Abigail Spanberger delivered the party’s official response, emphasizing the burden of rising costs on American families and safety concerns about federal immigration enforcement.  

    Rep. Al Green, D-Texas, was escorted from the chambers after holding up a large sign that said, “Black people aren’t apes,” referencing a video Trump recently posted on Truth Social depicting President Barack Obama and First Lady Michelle Obama as apes. Green was similarly removed during Trump’s 2025 address to Congress after protesting the president’s speech.

    At another point, Rep. Ilhan Omar, D-Minn., shouted at Trump, accusing him of killing Americans, referring to the shooting deaths of two U.S. citizens in her state, Renee Good and Alex Pretti, by federal immigration agents.

    Several other lawmakers wore pins that read “release the files” in reference to documents related to the late sex-offender Jeffery Epstein. 

    Many Democrats attended events organized by liberal groups elsewhere in Washington, D.C. 

    The advocacy group MoveOn and left-leaning media outlet MeidasTouch planned a rally they dubbed the “People’s State of the Union.” Gathered on the National Mall, attendees spoke about immigration policy and the Epstein files. Several senators and U.S. representatives spoke.

    Pro-democracy, anti-Trump advocacy group Defiance.org hosted another event, with speakers including lawmakers and mayors whose cities have been targets of Trump’s immigration crackdowns. The event was dubbed the “State of the Swamp,” and many guests sported frog-themed hats and headbands — a reference to the peaceful protest movement known as the Portland Frog Brigade, members of whom were in attendance. 

    We fact-checked some of the Democrats’ Feb. 24 remarks.

    Spanberger: Trump’s policies “have forced American families to pay more than $1,700 each in tariff costs.” 

    Estimates vary, but research supports this number. 

    Spanberger’s office pointed to research from the Democrats on Congress’ Joint Economic Committee, which estimated that the average U.S. household has paid about $1,745 in tariff costs from February 2025 to January. 

    Other groups estimated lower tariff burdens, from $1,000 per household to $1,230 per household

    One group’s figure was higher than Spanberger’s: In August, the National Taxpayers’ Union estimated that tariffs added $2,048 to U.S. households’ tax burden.

    Spanberger: “Rural health clinics in Virginia and across the country are already closing their doors” because of Trump’s signature One Big Beautiful Bill Act. 

    This is accurate.

    On Sept. 4, 2025, two months after Trump signed the bill into law, Virginia health care company Augusta Medical Group announced it was closing three rural clinics. The company said its consolidation was part of its “ongoing response to the One Big Beautiful Bill Act and the resulting realities for healthcare delivery.”

    Other companies have closed locations or consolidated services, saying the changes followed physician shortages and recent congressional cuts to Medicaid.

    Trump’s tax and spending law is expected to reduce federal Medicaid spending in rural areas by at least $137 billion by 2034, according to an analysis by KFF, a health policy research organization. The Congressional Budget Office predicts the law will raise the number of uninsured patients by 10 million by 2034.

    Rural health facilities disproportionately rely on Medicaid reimbursement to stay afloat. In 2023, 40.6% of children and 18.3% of adults under age 65 from rural areas and small towns were enrolled in Medicaid.

    Trump’s tax and spending law includes the Rural Health Transformation Program, a one-time $50 billion investment in rural health funding. But the new funding source will not offset what rural health facilities lose from the Medicaid cuts.

    Connecticut Sen. Chris Murphy: “Millions of Americans are losing their health care.” 

    Early data supports Murphy’s figure, which he cited while speaking at the “People’s State of the Union” rally

    On Jan. 1, enhanced tax credits that helped reduce health care costs for most people purchasing insurance through Affordable Care Act marketplaces expired. KFF estimated that premium costs would more than double in 2026 for Affordable Care Act enrollees. Anecdotal reports show some people have dropped their insurance, citing rising costs.

    Health analysts and the Congressional Budget Office reported that the subsidies’ expiration would cause rising costs that would trigger millions of Americans to forgo health insurance coverage. Early Centers for Medicare & Medicaid Services data signals that about 1.5 million people may have dropped their insurance in 2026. 

    [ad_2]

    Source link

  • EPA scraps Biden coal restrictions as advocates say move will restore American dominance

    [ad_1]

    NEWYou can now listen to Fox News articles!

    A leading domestic energy advocacy group praised EPA Administrator Lee Zeldin’s announcement that his agency would undo recent additions to the federal “mercury and air-toxics standards” (MATS) for coal-fired power plants.

    Zeldin said removing the restrictions allows the already “robust” MATS standards to remain in effect, ensuring both public health and the health of America’s coal industry amid a push for U.S. energy dominance.

    “The Biden-Harris Administration’s anti-coal regulations sought to regulate out of existence this vital sector of our energy economy. If implemented, these actions would have destroyed reliable American energy,” Zeldin said at the Mills Creek Power Plant in Kentucky, adding that protecting the environment and supporting industry and baseload power is not a “binary choice.”

    In response, Power the Future founder Daniel Turner told Fox News Digital the move is a significant step toward revitalizing the American coal industry and, in turn, fueling economies in economically depressed industrial communities throughout Appalachia and beyond.

    TRUMP DIRECTS MILITARY TO STRIKE NEW DEALS WITH COAL-FIRED POWER PLANTS: ‘GOING TO BE BUYING A LOT OF COAL’

    “Since the war on coal, we have weakened our grid, driven electricity prices through the roof, outsourced major industries to Mexico and China, but most of all driven tens of thousands of Americans into ruin because of a globalist agenda,” Turner said Friday, adding that the costs of a crippled coal industry went far beyond shuttered infrastructure:

    “The cruel Obama-led war on coal ruined numerous towns across rural America, drove families into poverty, caused alcoholism, opioid addiction, domestic violence, and suicide to skyrocket.”

    “Power The Future started because of coal miners, the acceptable casualties in the globalist climate change agenda,” said Turner, whose group is based in coal-heavy Virginia.

    EPA CHIEF WRAPS NATIONAL TOUR AS CRITICS SLAM DEREGULATION AGENDA

    “Restoring America’s coal dominance is good for our national security and economy, and it restores the dignity of small-town coal workers whose labor is vital to America’s survival.”

    Many of America’s poorest counties are in what were once very wealthy coal communities — including McDowell and Mingo counties in West Virginia and Bell, Letcher, McCreary, and Breathitt counties in Kentucky, where Vice President JD Vance’s family is from.

    During much of the 20th century, McDowell County — and its seat, Welch — was the No. 1 coal-producing county in the U.S. and home to 100,000 people — a population boom some credit with spurring construction of what became the nation’s first parking deck, which is still standing today in Welch.

    TRUMP ADMIN RELAUNCHES KEY COUNCIL AFTER BIDEN ADMIN SHUTTERED IT: ‘IGNORANCE AND ARROGANCE’

    Now, about one-quarter of McDowell residents live in poverty while the median income is around $30,000.

    Turner alluded to those conditions in comments to Fox News Digital, saying people must “never forget or forgive the drivers of the war on coal for their cruel attacks on a vital industry found only in rural America.”

    “[Anti-coal politicians] fly private jets to attend global climate summits while they orchestrated an evil attack on the coal miner making America weaker and China richer.”

    Turner quipped that any “anti-coal activist” is invited to join him in visiting coal-producing communities but may be unhappy to get dirt on their clothing and find lodging not up to “Four Seasons” standards.

    “We need coal. There is not one product around you right now that was not touched by coal, and to lower prices, bring market stability and ensure economic growth, we need to dominate the coal industry,” Turner said.

    The Mill Creek power plant in Kentucky, where Lee Zeldin made his announcement, is seen. (Jon Cherry/Getty Images)

    CLICK HERE TO DOWNLOAD THE FOX NEWS APP

    “Sadly, the liberal elite who launched the war on coal are too ignorant or too indifferent to know this. The ignorant can be educated, and that’s what I try to do at Power The Future. But the indifferent must be defeated, as they are a threat to our liberty, property and prosperity. I will never stop until I defeat them all,” he said, calling President Donald Trump the “greatest coal president in history.”

    Former EPA Administrator Gina McCarthy fired back at the policy change, telling the AP that “by weakening pollution limits and monitoring for brain-damaging mercury and other pollutants, they are actively undermining any attempt to make America — and our children — healthy.”

    [ad_2]

    Source link

  • Colorado medical device company admits to fraud scheme, agrees to pay DOJ millions in penalties

    [ad_1]

    A Colorado medical device company admitted to orchestrating an elaborate health care fraud scheme that resulted in the overbilling of patients and insurers by hundreds of millions of dollars.

    Zynex Inc., an Englewood-based firm that manufactures and sells medical devices used for pain management and rehabilitation, entered into an agreement Tuesday with the U.S. Department of Justice to avoid prosecution.

    The company, as part of the deal, agreed to pay between $5 million and $12.5 million in penalties — the final tally will depend on its earnings and profit during the settlement period — and will forfeit millions of dollars in unpaid claims.

    Zynex admitted to participating in a conspiracy to commit health care fraud, securities fraud, mail fraud and other violations, the U.S. Attorney’s Office for the District of Rhode Island announced in a news release.

    The agreement comes a month after a federal grand jury indicted two former top Zynex executives who allegedly spearheaded the years-long scheme.

    Zynex, in its deal with the government, also admitted to collecting more than $873 million for its products, including more than $600 million for supplies, “the vast majority of which were the result of fraud,” investigators said.

    Have you used Zynex for medical devices? We want to talk to you.

    The company acknowledged that it shipped and billed for medically unnecessary supplies in excess quantities and misled investors who were unaware of the fraudulent billing practices.

    [ad_2]

    Source link

  • Have you used Zynex for medical devices? We want to talk to you.

    [ad_1]

    Two former executives at a Colorado-based medical device company last month were charged in connection with orchestrating an alleged health care fraud scheme that federal prosecutors say raked in more than $800 million.

    Zynex, based in Englewood, shipped patients excessive volumes of devices each month, using these fraudulent billings to artificially inflate the company’s financial reporting and its stock price, the government alleged.

    The Denver Post wants to hear from those who have received Zynex supplies and devices.

    Reporter Sam Tabachnik is working on a story about the alleged scheme and wants to hear about the experiences of patients who dealt with this company. Let us know below.

    [ad_2]

    Source link

  • Can TrumpRx help you save money on drugs? Here’s what experts say.

    [ad_1]

    After last week’s launch of TrumpRx, President Trump described the discounted drug platform as “one of the most transformative health care initiatives of all time.” But experts and health care advocates said that limitations with the new service could undermine its value to consumers.

    “The prices are absolutely cheaper than list prices, but only for cash patients or patients whose insurance does not sufficiently cover these drugs,” Yunan Ji, a health policy expert at Georgetown’s McDonough School of Business, told CBS News. “For a small share of the market, it will deliver meaningful savings, but it is not going to change the whole drug pricing landscape for most Americans.”

    Anthony Wright, executive director of Families USA, an advocacy group for health care consumers, applauded the Trump administration’s effort to lower drug prices for Americans. But he said TrumpRx doesn’t serve as a “one-stop shop” for consumers who want to compare drug prices and secure the lowest costs, describing the system as more of a “catalog of coupons from existing programs from drug companies.”

    Wright also said he’d like to see TrumpRx offer a broader range of drugs, including those used to treat cancer and other diseases (see below for a list of all drug discounts available through TrumpRx.) 

    The White House told CBS News that such discounts only exist because the Trump administration negotiated so-called “most-favored-nation” agreements with pharmaceutical firms to lower prices. Under that policy, drugmakers must sell meds to U.S. customers at the same prices available in other countries, including those with lower drug costs. 

    TrumpRx is also focused on offering the lowest prices on branded products, the White House noted, acknowledging that more affordable generic versions of the drugs may be available elsewhere. 

    Who is TrumpRx for?

    A drawback of TrumpRx is that discounts are available only to patients who buy drugs in cash, Wright said. That means people must pay for prescriptions out of pocket and can’t use their health insurance, while those expenses will not count toward meeting a consumer’s health plan deductible. 

    “It is focused pretty narrowly on people who are uninsured and are buying prescription drugs with cash rather than through a health plan,” Wright told CBS News.

    When TrumpRx launched on Feb. 5, the site listed more than 40 brand-name drugs, with the Trump administration saying that more discounted medications will be added over time. 

    Merith Basey, CEO of Patients For Affordable Drugs Now (P4ADNow), a national patient organization that works to lower drug prices, said the coupons TrumpRx offers are not unique to the platform, noting that similar discounts are already available in the marketplace.

    To assess the savings available through TrumpRx, the group compared the service with what consumers can find for the same drugs via GoodRx, a Santa Monica, Calif., company that offers discounted meds. TrumpRx’s pricing was superior for only eight drugs, P4ADNow found, as follows:

    • Bevespi (chronic bronchitis) — 89% discount through TrumpRx
    • Cetrotide (fertility)  — 93% discount through TrumpRx
    • Farxiga (Type 2 Diabetes) — 52% discount through TrumpRx
    • Genotropin (human growth hormone) — 60% discount through TrumpRx
    • Insulin Lispro (blood sugar control) — 65% discount through TrumpRx
    • Ovidrel (fertility) — 67% discount through TrumpRx
    • Xigduo XR (Type 2 Diabetes) — 70% discount through TrumpRx
    • Zepbound (weight loss) — 72% discount through TrumpRx

    GoodRx offered equally steep discounts on 33 of the drugs listed on TrumpRx, while cheaper generic alternatives were available for 15 TrumpRx medications, according to the group’s analysis. 

    For example, Colestid, a drug that lowers cholesterol for people at risk of heart disease, costs $67.20 if purchased through TrumpRx, while a generic version of the drug costs $21.70.

    Most insurers don’t cover weight-loss drugs like Ozempic and Wegovy. TrumpRx and GoodRx both offer Ozempic for $199 for a 0.25 milligram pen, which has a list price of over $1,000. 

    The same is typically true of fertility drugs, including Gonal-F, which costs $252 with a TrumpRx or GoodRx coupon and which has a list price of nearly $1,200.

    Drug discounts available through TrumpRx

    For now, TrumpRx offers discounts on a total of 43 drugs, as follows:

    • Abrilada pen (autoimmune) — TrumpRx price: $207.60
    • Airsupra (respiratory) — TrumpRx price: $201
    • Azulfidine Tabs (rheumatology) — TrumpRx price: $99.60
    • Azulfidine En Tabs (rheumatology) — TrumpRx price: $130.80
    • Bevespi (respiratory) — TrumpRx price: $51
    • Cetrotide (IVF) — TrumpRx price: $22.50
    • Chantix (smoking cessation) — TrumpRx price: $106.20
    • Cleocin (antibiotic) — TrumpRx price: $94.35
    • Colestid (cholesterol) — TrumpRx price: $127.91
    • Cortef (inflammation) — TrumpRx price: $45
    • Cytomel (thyroid) — TrumpRx price: $6
    • Diflucan (antifungal) — TrumpRx price: $14.06
    • Duavee (women’s health) — TrumpRx price: $30.30
    • Estring (women’s health) — TrumpRx price: $249
    • Eucrisa (dermatologic) — TrumpRx price: $158.48
    • Farxiga (diabetes, cardiovascular) — TrumpRx price: $181.59
    • Genotropin (human growth hormone) — TrumpRx price: $89.67
    • Gonal F (fertility) — TrumpRx price: $168
    • Insulin Lispro (high blood sugar) — TrumpRx price: $25
    • Levoxyl (hypothyroidism) — TrumpRx price: $35.10
    • Lopid (cholesterol) —TrumpRx price: $39.60
    • Medrol (inflammation) —TrumpRx price: $3.15
    • Ngenla (human growth hormone) — TrumpRx price: $2,217
    • Nicotrol (smoking cessation) — TrumpRx price: $271.16
    • Ovidrel (fertility) —TrumpRx price: $84
    • Ozempic Pen (diabetes, weight loss) — TrumpRx price: $199
    • Premarin (women’s health) — TrumpRx price: $99
    • Premarin Vaginal Cream (women’s health) — TrumpRx price: $236.65
    • Prempro (women’s health) — TrumpRx price: $98.84
    • Pristiq (antidepressant) — TrumpRx price: $200.10 
    • Protonix (heartburn) — TrumpRx price: $200.10
    • Tikosyn (cardiovascular) — TrumpRx price: $336
    • Toviaz (bladder control) — TrumpRx price: $43.50
    • Vfend (antifungal) — TrumpRx price: $306.98
    • Viracept (antiviral) — TrumpRx price: $607.20
    • Wegovy (weight loss) — Pen TrumpRx price: $199
    • Wegovy Pill (weight loss) — TrumpRx price: $149
    • Xeljanz (rheumatology) — TrumpRx price: $1,518
    • Xigduo Xr (diabetes) — TrumpRx price: $181.59
    • Zarontin (anticonvulsant) — TrumpRx price: $71.10
    • Zavzpret (migraine treatment) — TrumpRx price: $594.84
    • Zepbound (weight loss, sleep apnea) — TrumpRx price $299
    • Zyvox (antibiotic) — TrumpRx price: $122.74

    [ad_2]

    Source link

  • FDA Refuses to Review Moderna’s New Flu Shot

    [ad_1]

    The U.S. Food and Drug Administration (FDA) recently informed Moderna that it would not review the company’s application for approval of its new flu vaccine, which is its first using mRNA technology for influenza.

    The FDA has been going back and forth with Moderna for nearly two years since the company submitted Phase 3 data on the vaccine. That data showed the effectiveness of the mRNA flu vaccine, called mRNA 1010.6, when compared to existing flu shots.

    Moderna posted on its website a timeline of its communications with the FDA, in which the agency asked for additional information comparing how Moderna’s flu shot stacked up against existing ones for older people, who are more vulnerable to flu complications. The company says it started a Phase 3 study in 2025 involving more than 40,000 people over age 50—some of whom took mRNA 1010.6, and others who took the flu shot Fluarix.

    In the FDA’s letter to Moderna, which the company posted on its website, the agency said the application “is not sufficiently complete to enable a substantive review.” Dr. Vinay Prasad, director of the Center for Biologics Evaluation and Research (CBER) at FDA, signed the letter and faulted the lack of data on a control against which Moderna’s flu vaccine can be compared. “CBER does not consider the application to contain a trial ‘adequate and well-controlled’ and the application is therefore, on its face, inadequate for review. This is because your control arm does not reflect the best-available standard of care in the United States at the time of the study.”

    According to reporting by STAT, Prasad made the decision against the advice of staff at FDA, who recommended reviewing the application and were prepared to do so. The decision reflects growing scrutiny and restrictions on vaccines under the Trump Administration; Prasad also overruled FDA staff in limiting yearly COVID vaccines to people over 65 and those with weakened immune systems.

    Read More: The New Way to Predict Your Risk of a Heart Attack

    At issue with Moderna’s mRNA flu shot is communication from CBER to Moderna suggesting that the company’s vaccine be compared against a control shot designed more specifically for older people. Moderna says the FDA didn’t directly request any changes to the design of the study.

    FDA spokesperson Andrew Nixon said in a statement, however, that “the FDA rejected Moderna’s application for filing because the company refused to follow very clear FDA guidance from 2024 to test its product in a clinical trial against a CDC-recommended [high-dose] flu vaccine to compare safety and efficacy,” and said “Moderna exposed participants age 65 and over to increased risk of severe illness by giving them a substandard of care against the recommendation of FDA scientists.”

    Moderna maintains that the company provided the needed control comparison for older people. “The letter is inconsistent with previous written communications from CBER to Moderna,” the company said in a statement. The company also says “CBER did not raise any objections or clinical hold comments about the adequacy of the Phase 3 trial after the submission of the protocol in April 2024 or at any time before the initiation of the study in September 2024.”

    Moderna’s mRNA flu vaccine is being reviewed outside of the U.S.—in Europe, Canada, and Australia—and the company plans to submit requests for approval in other countries as well this year.

    Read More: 8 Phrases That Will Instantly Get Your Doctor’s Attention

    The FDA’s decision could mean that people in other countries would get the first mRNA flu shots before Americans do. One important advantage of the mRNA technology is its speed; currently, the World Health Organization reviews data from flu cases in the southern hemisphere before making a recommendation about which strains seem to be causing the most disease, and recommending those for the next yearly updated flu shot. That generally happens in the spring, ahead of the fall and winter flu season in the northern hemisphere, which includes the U.S. and Europe. About 80% of current flu shots are made by growing the influenza virus in chicken eggs, which requires months of advance planning. Some shots are made with more modern technology, such as cell-based platforms, but the majority are still made using decades-old methods that take time.

    mRNA technology, on the other hand, takes just weeks to incorporate new virus strains, as the world saw with the quick development of the COVID vaccines matched to the strains causing the most disease. mRNA based technology could help health officials to respond more quickly to changing varieties of influenza, and ultimately prevent and protect against more disease.

    Since taking office in January, the Trump Administration has been dismantling existing policies and recommendations about vaccines. Secretary of Health and Human Services (HHS) Robert F. Kennedy Jr., who oversees the major health agencies including FDA and the U.S. Centers for Disease Control and Prevention (CDC), has removed and replaced members of the CDC’s expert committee that reviews and makes recommendations about which Americans should receive which vaccines. He also removed recommendations for most children and adults to get annual flu and COVID shots. Earlier this year, HHS canceled a $590 million contract with Moderna to develop an mRNA-based bird flu vaccine, before Kennedy said the government’s Biomedical Advanced Research and Development Authority, which was involved in that development, would be “winding down” mRNA vaccine work in favor of other platforms.

    [ad_2]

    Alice Park

    Source link

  • Colorado sues to block Trump administration from cutting public health grants

    [ad_1]

    Colorado filed a lawsuit Wednesday to prevent the Trump administration from canceling more than $20 million in grants for public health.

    On Monday, the U.S. Department of Health and Human Services notified Congress it wouldn’t pay $600 million worth of grants already awarded in Colorado, California, Illinois and Minnesota — all states led by Democratic governors.

    The four states asked a federal court in Illinois’ Northern District to issue an order preventing the federal government from withholding the funds while their lawsuit plays out.

    Colorado Attorney General Phil Weiser’s office said the existing grants totaled about $22 million, and the cuts would reduce Colorado’s public health funding in the future by an estimated $4 million.

    The funding comes through the Centers for Disease Control and Prevention and goes toward developing the public health infrastructure and workforce, as well as finding and preventing sexually transmitted infections.

    One of the recipients in Colorado that will lose funding is using it to increase HIV testing around Denver and Colorado Springs, with a focus on gay and bisexual men of color.

    [ad_2]

    Meg Wingerter

    Source link

  • Douglas County woman billed Medicaid for patient who already died, federal officials allege

    [ad_1]

    Federal officials unveiled a slew of charges Tuesday against two Coloradans accused of ripping off a program that provides free rides to Medicaid patients, the first criminal charges filed in response to a sprawling fraud bonanza identified by state officials more than two years ago.

    The indictments allege that Ashley Marie Stevens and Wesam Yassin separately participated in the transportation program and fraudulently collected seven-figure payouts — more than $3.3 million for Yassin alone, according to a statement from the U.S. Attorney’s Office in Colorado. The two drivers, who ran separate companies, allegedly fabricated rides for appointments that didn’t exist. Stevens is accused of billing for rides for her husband while he was incarcerated, and Yassin allegedly billed $165,000 for driving a patient who was dead.

    Both Stevens, of Mesa County, and Yassin, of Douglas County, were charged with multiple counts of wire fraud, money laundering and health care fraud for their participation in the driving service.

    The program pays drivers to ferry Medicaid patients to and from doctor’s appointments, but it became a haven for fraud in 2022 and 2023, after state officials increased the service’s reimbursement rates. State officials told The Denver Post last month that an estimated $25 million was lost in the broader fraud.

    Yassin’s indictment was still sealed Tuesday evening. In a statement, federal officials alleged that Yassin billed Medicaid for hundreds of thousands of dollars worth of rides that never occurred between March 2022 and October 2023. She raked in $283,000 from rides for just one patient, most of which was paid to Yassin after the patient had already died.

    Yassin allegedly used the proceeds to buy a home and furnishings, along with luxury vehicles, jewelry and cosmetic surgery. She was released on bond earlier this week, according to court records.

    Stevens billed the state for more than $1 million between July 2022 and February 2023, according to the indictment. More than $400,000 came from rides she provided to herself or to her family members, for which there were “very few” actual medical appointments, federal authorities allege.

    The trips included rides for her husband, who was incarcerated during some of the time when Stevens claimed she was driving him to the doctor. Another $150,000 was billed for rides that either never took place or were for trips that didn’t involve Medicaid services.

    [ad_2]

    Source link

  • White House launches TrumpRx discounted drug site

    [ad_1]

    The Trump administration launched its new TrumpRx prescription drug listing site late Thursday, part of a push by President Trump to offer lower direct-to-consumer drug prices.

    The president struck deals last year with more than a dozen drugmakers to list some of their medication on TrumpRx at steep discounts from list prices, with megacompanies like Pfizer and Novo Nordisk — known for weight loss and diabetes drugs Ozempic and Wegovy — signing on.

    The site lists dozens of prescription drugs at reduced rates. For example, a four-week supply of Wegovy injection pens is listed at $199 for the first two months and $349 after that, well below the list price of $1,349.02. Novo Nordisk has offered Wegovy for similarly discounted prices through its NovoCare Pharmacy program in recent weeks.

    A unit of Gonal-F, a common drug used as part of the in vitro fertilization (IVF) process, is listed on TrumpRx at $252, an 83% discount from the sticker price. Mr. Trump pledged on the campaign trail to ensure that fertility treatments are fully covered either by private insurance or the government.

    The site does not sell drugs directly — instead, users are prompted to print out a gold-embossed coupon that it says can be used at pharmacies.

    In a White House event Thursday evening, Mr. Trump called it “one of the most transformative health care initiatives of all time.” The administration’s Chief Design Officer Joe Gebbia, an Airbnb founder who helped design the site, said more drugs will be added to TrumpRx over time.

    It’s not clear how much of an impact TrumpRx will have on the prices most Americans pay for prescription drugs. 

    Most people pay for their medication through insurance rather than out-of-pocket, so the discounts offered by TrumpRx may not change what they pay. The site notes: “If you have insurance, check your co-pay first—it may be even lower.”

    “The direct-to-patient stuff is, in my view, a sideshow and branding opportunity for Trump,” Sean Sullivan, a health economist at the University of Washington, told CBS News last year. “Most patients have drug coverage. … Very few are going to buy medications with cash, unless the drug is not a covered benefit, like weight loss or erectile dysfunction drugs.”

    But steeply discounted direct-to-consumer options could matter for uninsured Americans, people with high deductibles and patients whose medications aren’t covered by their insurance — including some users of weight loss and IVF drugs.

    “You should not be buying drugs anymore, going forward, without at least checking to see if those medications are available at these discounted prices,” Dr. Mehmet Oz, the administrator of the Centers for Medicare and Medicaid Services, said Thursday.

    Mr. Trump has pressed drugmakers for months to slash their prices.

    Beyond TrumpRx, he has cut deals with several pharmaceutical companies to offer their drugs to Medicaid patients at most-favored-nation prices, meaning they cannot charge more than the prices paid by people in other high-income countries. The companies also agreed to offer most-favored-nation pricing for new drugs introduced in the U.S.

    The fact that Americans tend to pay far higher drug prices than their European peers has long vexed members of both parties. For years, lawmakers have proposed capping U.S. drug prices or tying them to the prices paid in foreign countries, though pharmaceutical companies have typically pushed back, warning that price caps could make it harder to pay for research into new drugs.

    “Americans have long been paying the highest drug prices anywhere in the world while other countries often paid pennies on the dollar for the exact same drugs,” the president said Thursday. “We were essentially subsidizing the entire world.”

    Pharmaceutical companies routinely raise prices at the beginning of each year, and 2026 has been no exception, drug pricing experts told CBS News.

    Manufacturers raised list prices of 947 brand-name drugs this January, while lowering prices on 20, according to drug pricing research nonprofit 46brooklyn. The list prices for brand-name drugs — which are like the sticker prices set by drugmakers before rebates or other discounts are negotiated — increased by a median of 4% so far in 2026, on par with last year’s increase. 

    The size of annual increases has fallen in the last decade amid public backlash over high drug costs, but last year’s increases still outpaced the inflation rate.

    Data from 46brooklyn does show that in a few cases, list prices for widely used drugs have fallen substantially. The list price of Eliquis, a blood thinner, plunged 43%, while Jardiance, used to treat Type 2 diabetes, fell 44%. Both drugs were among the first 10 medications selected for Medicare price negotiations through a Biden-era provision in the Inflation Reduction Act.

    The Consumer Price Index for prescription drugs — which tracks transaction costs rather than list prices — has also risen 2% between December 2024 and December 2025. And since January 2025, when Mr. Trump was inaugurated for his second term, the index has declined by less than 1%. 

    [ad_2]

    Source link

  • Concerns about health care costs after Affordable Care Act tax credits expire

    [ad_1]

    According to a new KFF Health tracking poll, two-thirds of those surveyed say they worry about not being able to afford health coverage and more than half say costs have gone up in the past year. Renuka Rayasam, senior correspondent at KFF Health News, joins CBS News to discuss.

    [ad_2]

    Source link

  • 8 Phrases That Will Instantly Get Your Doctor’s Attention

    [ad_1]

    Doctors don’t just examine bodies—they also decode language. And some words and phrases make them lean in, ask more questions, and rethink what might be going on.

    A clear, detailed conversation with a patient “gets you 80% there on a diagnosis,” says Dr. Robert Biernbaum, chief medical officer at WellNow Urgent Care, which has locations in five states. “That’s how important words are. They’re the most important thing we do in adult medicine.”

    There’s no need to use medical jargon you picked up while Googling your symptoms, he adds. If a patient informs him they think they have pneumococcal pneumonia, for example, that sets the diagnostic process back: He has to start over and ask them why they think that. The most helpful language is honest and specific, and focuses on change over time and day-to-day impact, Biernbaum adds.

    We asked doctors which phrases always catch their attention—and why.

    “This has been going on for months”

    When you’re describing symptoms to your doctor, it’s key to include how long they’ve been going on. You might use a word like “persistent,” says Dr. James Tacci, president-elect of the American College of Preventive Medicine. His patients commonly phrase things like this: “I thought it was going to go away but it didn’t,” or “I didn’t want to bother you at first, but it’s still here.”

    “The fact that any abnormality is persistent makes it more than trivial,” he says. “It makes it more than transient. It doesn’t necessarily mean that it’s bad, or that it’s going to be significant clinical findings, but it means it’s something that needs to be addressed.”

    “My symptoms are getting worse”

    If doctors hear words like “worsening” or “progressive,” they’re going to flag it. Both terms signal that a condition isn’t stabilizing or improving—and may require faster intervention or a different approach.

    Read More: 10 Questions You Should Always Ask at Doctors’ Appointments

    “Modern life has trained people to downplay their symptoms,” says Dr. Nicholas Cozzi, an emergency physician and EMS medical director at Rush University Medical Center. “Social media frames illness as weakness or inconvenience.” But minimizing how you feel can delay care. Being honest about worsening symptoms helps clinicians gauge urgency and respond appropriately, he says.

    “I had to stop doing X”

    One of the most important things doctors want to know is how much symptoms are changing your daily life. Biernbaum is especially alert to phrases like “interfering with sleep,” “can’t work,” “can’t eat,” “can’t walk,” and “I had to stop doing X.”

    “When people start saying things like, ‘I haven’t missed a day of work in five years and I had to call in because I can’t work because the pain is too bad,’ you listen,” he says. It’s a powerful way of assessing severity, he adds, and often triggers a more thorough evaluation.

    “This is more severe than the last migraine I had”

    Doctors often ask patients to rate their pain on a scale of 1 to 10—but those numbers don’t always tell the whole story. “Everyone’s pain threshold is different,” says Dr. Adam Stracher, chief medical officer and director of primary care at Weill Cornell Medicine. Instead, he wants patients to describe how this pain stacks up against what they’ve felt before. “If patients have headaches all the time, but usually they’re a 4 or 5, and this is a 10,” that’s a more meaningful comparison, he says. It signals a change from the baseline—and raises concern that something different may be going on.

    “I had a sudden change in strength”

    The word “sudden” signals that the timeline has shifted in an important way, often prompting more urgent questions and testing. Stracher pays particular attention to phrases like these: “sudden loss of vision,” “sudden shortness of breath,” “sudden change in strength,” and “sudden abdominal pain.” 

    “The sudden, acute onset of anything gives us a higher level of suspicion” that something urgent is wrong, he says.

    “I’m short of breath”

    There’s a set of symptoms that immediately register as warning signs in Biernbaum’s mind. Among them: “short of breath,” “fainting,” “weakness,” “numbness,” “vision changes,” “unintentional weight loss,” and “blood.” These elevate concern because they’re linked to high-risk diagnoses, he says, which means they often call for faster work-ups or referrals.

    When he hears this kind of complaint, Biernbaum asks targeted follow-ups: “You’ve been complaining your foot is numb. When does that happen? Is it all the time? Has it gotten progressively worse?” Or: “Are you short of breath now? How did you get here? Were you able to walk in?”

    “We have to ask those questions because when people bring out those red-flag symptoms, we really need to understand what it means to them,” he says. Someone who says they’re short of breath and had to be helped into the clinic, for example, raises a very different level of concern than someone who parked three blocks away and still managed to breeze in.

    “I have sharp chest pain that worsens with exertion and improves with rest”

    A helpful rule of thumb: Precision beats vagueness. Providers respond most strongly to clear, concrete descriptions, Biernbaum says, rather than broad statements like you’ve never felt worse in your life.

    “When people don’t feel good—including myself—we can bring drama into the conversation,” he says. But doctors need specifics about timing, triggers, and symptoms to make the best decisions. For example, telling your provider that your fever jumped to 103.4 overnight and you have a deep cough immediately changes how they think about what could be going on. “Now it’s going from a cold to, could this be pneumonia?” he says. “Very precise descriptions are so important for us to get to the bottom of something.”

    “I have a family history of X.”

    Your family medical history might be recorded in your patient portal. But that doesn’t necessarily mean your doctor read every line—or that he remembers your dad had a heart attack at 52 or your grandmother was diagnosed with breast cancer in her 40s.

    Read More: 8 Ways to Shorten Your Wait for a Doctor’s Appointment

    “It makes so much difference if you have a family history of whatever it is that you’re being tested for or whatever symptom you’re worried about, because it puts you in a whole new category,” Tacci says. “That makes every physician appropriately stop, take pause, and say, ‘OK, let’s make sure we’re on the right page for you based on your genetics.’”

    [ad_2]

    Angela Haupt

    Source link

  • 5 ways to find affordable care without health insurance

    [ad_1]

    Health policy changes in Washington will ripple through the country, resulting in millions of Americans losing their Medicaid or Affordable Care Act coverage. But there are still ways to find care.

    Over the next decade, the GOP’s One Big Beautiful Bill Act is expected to slash nearly $1 trillion in spending from Medicaid, the state-federal program for people with low incomes and disabilities. The implementation of new work rules will cause some beneficiaries to lose their Medicaid coverage.

    Millions of Americans are facing enormous increases in their out-of-pocket costs for ACA coverage. So far, 1.2 million fewer people have signed up for Obamacare plans compared with last year, and health policy analysts estimate more will lose coverage as they fail to pay their premiums.

    Health costs are a top concern for Americans. Two-thirds of the public say they are somewhat or very worried about affording health care, more than express the same worries about utilities, food, housing, or gas, according to a January poll from KFF, a health information nonprofit that includes KFF Health News.

    “All of this pain just doesn’t have to be there,” said Cheryl Fish-Parcham, director of private coverage at the health consumer group Families USA.

    Doctors and health policy researchers say health coverage, of any kind, is the best protection against major medical debt.

    Caitlin Donovan, a senior director at the Patient Advocate Foundation, recommends exhausting every available option for health coverage before going uninsured.

    Even a high-deductible plan can protect patients from medical bankruptcy “if the absolute worst-case scenario happens,” she said.

    Here are five ways that the uninsured can find affordable care.

    1. Don’t be afraid to talk with your doctor about money

    Patients can be hesitant to tell their doctors they’re uninsured or be wary of expressing concern about being able to afford care.

    But some hospitals, physicians, and other providers offer cheaper cash pay options, said Cynthia Cox, a senior vice president and the director of the Program on the ACA at KFF.

    Often prices are negotiable. “Always ask,” she said.

    Health care providers can make adjustments if they know patients are worried about money, said Ateev Mehrotra, a doctor and researcher at Brown University.

    “If my patient tells me, ‘Doc, I’m gonna have to pay for this out-of-pocket,’ I’m gonna make a different risk calculus,” Mehrotra said.

    That doesn’t mean a patient won’t get the care they need, he said. A doctor, for instance, might order an ultrasound instead of an MRI, which is more expensive.

    2. Search for providers that specifically work with uninsured patients

    If your usual provider won’t budge on prices, then search for providers that cater to patients without insurance.

    Federally qualified health centers, or FQHCs, and other community clinics offer routine and non-emergency care, such as treatment for flu or infection, for low-income residents and the uninsured. Community health centers charge based on a sliding scale and see 52 million patients annually in some of the country’s most underserved areas, according to the National Association of Community Health Centers.

    The Trump administration has made funding cuts that might lead some of the country’s approximately 1,500 FQHCs to close or cut services. But the administration still maintains a site to find a local center.

    Planned Parenthood also accepts uninsured patients. Its centers test for sexually transmitted diseases, provide birth control options, and offer postpartum and gender-affirming care and other services.

    And the National Association of Free & Charitable Clinics also offers a tool to help people find free or low-cost care.

    Most community clinics don’t offer specialty care, but they can usually refer patients who need more intensive services to providers willing to work with uninsured patients.

    And academic medical centers tend to have more charity care programs that help uninsured patients lower their bills.

    “If you’re uninsured or even underinsured, you might be able to qualify for a significant discount on the cost of your care,” Cox said.

    Still, be wary of heading to the emergency room, which is the most expensive place to get care. While ERs are federally required to stabilize all patients regardless of their ability to pay, they can still leave you with a big bill — and often do.

    3. Call your local health department

    Health services vary widely from county to county, but many offer free vaccinations, family planning services, and testing for sexually transmitted infections, as well as for flu, covid, and tuberculosis.

    Some county health departments also offer more advanced care, such as dental services and mental health or substance abuse programs. And some states have consumer assistance programs that can guide residents in finding care, Fish-Parcham said.

    In addition, the Centers for Disease Control and Prevention’s National Breast and Cervical Cancer Early Detection Program makes free or low-cost breast and cervical cancer screenings available to low-income women in all states and territories. And some states cover screenings for other types of cancer as well.

    4. It’s easier to shop around for drugs than doctors

    Don’t just fill your prescription at the closest pharmacy. Instead, research generic drug options and look around for the best price on brand names.

    A handful of sites such as GoodRx and WellRx offer comparison shopping tools and information on other ways to get drug discounts.

    And some retailers offer low-cost access to common prescription drugs — at prices cheaper than you would find if you had insurance. Walmart, for instance, sells 90-day prescriptions of dozens of generic versions of drugs for $10. As does Target, Costco, and a new site called the Cost Plus Drug Company.

    Many drugmakers also offer patient assistance programs, coupons, and rebates on some medications. Check their websites for details on how to apply.

    States also offer drug assistance programs. The steps to qualify and types of drugs vary, but this tool has a list of programs and how they work.

    Joining a clinical trial is another way to access treatment. The National Institutes of Health and its National Cancer Institute have lists, but patients must first meet the criteria. Clinical trials aren’t necessarily free, even with insurance, Donovan said, so be sure to ask about any associated costs.

    5. Your diagnosis might lead you to specialized resources

    Patients with a specific diagnosis might have additional options for specialty treatment.

    For example, someone with breast cancer should check with the American Cancer Society and the nonprofit Susan G. Komen organization, Cox said.

    The Patient Advocate Foundation hosts a list of vetted foundations that can help offset the cost of medical bills and provide other resources such as transportation and lodging, Donovan said. Just type in basic information such as age, location, and diagnosis to see what is available.

    Disease-specific foundations such as those for lupus or irritable bowel syndrome can also steer patients to free or low-cost resources or cover some costs of care, Donovan said.

    “Everything is out there,” she said.

    As you research affordable care options, don’t be tricked by plans that look like health insurance but don’t offer guaranteed protection against big bills.

    Some short-term plans and health care sharing ministries might seem like good deals, but read the fine print. Some red flags to look for: too-good-to-be-true monthly payments; no coverage for preexisting conditions; morality clauses such as those prohibiting the use of alcohol or drugs; or a lack of coverage for benefits such as mental health counseling that are required in ACA plans.

    KFF Health News correspondent Sam Whitehead contributed to this report.

    Are you struggling to afford your health insurance? Or have you decided to forgo coverage? Click here to contact KFF Health News and share your story.

    KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF — the independent source for health policy research, polling, and journalism.

    [ad_2]

    Source link

  • University of Minnesota, Fairview reach new 10-year agreement

    [ad_1]


    The University of Minnesota Board of Regents says it approved a mediated agreement with Fairview and M Physicians on Friday.

    The 10-year agreement includes a $1 billion investment from Fairview in its medical facilities on the University of Minnesota campus and confirmation of the academic affiliation between the University of Minnesota and Fairview.

    “This agreement is an important milestone that brings clarity to the relationship between the University, M Physicians, and Fairview Health Services for the next 10 years,” University of Minnesota President Rebecca Cunningham said. “We are pleased to be able to continue this long-term partnership, which has played a vital role in caring for Minnesotans, training much of the state’s healthcare workforce and advancing lifesaving medical research.”

    The University of Minnesota and Fairview will also establish a new leadership council to “discuss important strategic matters and mutual needs and ensure an effective collaboration,” according to the Minnesota Attorney General’s Office.

    The new agreement will take effect on Jan. 1, 2027, with some features being implemented this year.  

    The three groups spent weeks negotiating a new contract, with the current 30-year agreement set to expire at the end of the year. The mediation team met every day for more than seven weeks starting Dec. 5, with the exception of Christmas.

    More than 30,000 employees and 10,000 union members work under the current agreement.

    [ad_2]

    Riley Moser

    Source link

  • Hennepin Healthcare cuts about 100 jobs as it makes changes to several services

    [ad_1]


    About 100 Hennepin Healthcare employees are losing their jobs as the system closes or integrates some of its standalone clinics and services.

    In a statement, Hennepin Healthcare said the cuts are “part of a broader, long-term effort to stabilize its finances and protect core clinical services and care capacity.”

    The health system said affected employees have already been notified.

    As part of the plan, Hennepin Healthcare will shift the following specialty services to primary care: senior care, sleep screenings and medical treatments for interventional pain.

    Nursing home services will be “transitioned to other systems,” Hennepin Healthcare said.

    Chiropractic, acupuncture and additional interventional services will be referred to external providers.

    Medical and surgical services for weight management will be integrated into the Clinic and Specialty Center.

    “Safe and high-quality care is our priority and will continue during the transition; patients with scheduled appointments should keep them until notified otherwise,” Hennepin Healthcare said. “We will ensure patients have quick and clear guidance on how to continue their care through referrals and other providers.”

    [ad_2]

    WCCO Staff

    Source link

  • The Cruel Conditions of ICE’s Mojave Desert Detention Center

    [ad_1]

    In November, Prison Law Office joined the firm of Keker, Van Nest & Peters, the A.C.L.U., and the California Collaborative for Immigrant Justice in filing a class-action lawsuit against ICE and the Department of Homeland Security on behalf of those detained at California City. As noted in the filing, detainees refer to C.C.D.F. as a “torture chamber” and “hell on Earth.” In fact, Borden says, the conditions at the facility are so terrible that detainees are resigning themselves to self-deportation, instead of pursuing asylum and other immigration cases, and that “people are also trying to take their own lives.”

    In April, 2025, as deportations ramped up nationwide, the for-profit prison company CoreCivic repurposed a decommissioned prison in California City into an immigration detention center after signing a contract with ICE. The company already owned the prison, which had sat unused since 2023, so the contract, which is worth an estimated a hundred and thirty million dollars annually, was a valuable source of revenue for CoreCivic. Additionally, the CoreCivic property has helped address ICE’s growing need for detention space in a state where the agency has turbocharged its immigration-enforcement activities. If fully occupied, C.C.D.F. will be the largest detention center on the West Coast—and one of its most remote.

    C.C.D.F. is situated two hours north of Los Angeles, deep in the Mojave Desert, and about sixty miles from the edge of Death Valley National Park. Temperatures can be below freezing in the winter, and well over a hundred degrees in the summer. “It’s hard for attorneys to get out there,” Mario Valenzuela, a lawyer who represents multiple clients at C.C.D.F, told me. It is a three-hour round trip from Valenzuela’s office in Bakersfield out to California City, and the detention center is so desolate that he often can’t find cell service. He told me, “There’s nothing around, just barren desert, then all of a sudden you come across this facility.”

    The closest town to C.C.D.F. is California City, about five miles away, where about a quarter of residents live below the poverty line, and roughly eighteen per cent are unemployed. As of 2024, CoreCivic is one of the town’s largest employers. But, despite signing a contract with ICE, ongoing litigation alleges that the company has not secured a business license or the proper conditional-use permit for the facility with the municipal government of California City. Since it opened, C.C.D.F. has allegedly been operating in direct violation of A.B. 103, a state law that requires a hundred-and-eighty-day waiting period and two public hearings before a private corporation may repurpose a facility as an immigration detention center. An active lawsuit is currently deciding these claims, but, even if the courts side with CoreCivic, the company seems to have acted in a legal gray zone when opening C.C.D.F.

    On August 27th, CoreCivic began receiving detainees at C.C.D.F. In September, a federally authorized monitor visit by Disability Rights California raised “serious concerns” about the facility’s significant disrepair, caused by the period it sat vacant and the subsequent “rush to open.” That month, five hundred migrants were believed to have been transferred to C.C.D.F. In November, Prison Law Office estimated that eight hundred detainees were being held at the facility, and by mid-January the count was fourteen hundred. C.C.D.F. is projected to reach its full capacity of two thousand five hundred and sixty people in the first quarter of 2026.

    “Any claims there are inhumane conditions at the California City Correctional Facility are FALSE,” the D.H.S. assistant secretary for public affairs, Tricia McLaughlin, said in an e-mail, adding that “ICE is regularly audited and inspected by external agencies” to insure its facilities comply with “national detention standards.” With regard to medical treatment, McLaughlin said that the agency provides “comprehensive medical care.” A representative for CoreCivic added that the company has “submitted all required information for a business license and [continues] to maintain open lines of communication with city officials.”

    Still, as detainee numbers have surged, staffing and basic infrastructure have clearly not kept up. In a letter sent to D.H.S. last month, California’s attorney general, Rob Bonta, warned that “the facility does not have enough medical doctors for its detainee population size,” and the staff it does have “appear to be inexperienced and lack basic understanding of civil detention management principles.” On January 20th, Senators Alex Padilla and Adam Schiff toured the facility and spoke with the warden as part of an oversight visit. “Far and away, the biggest concerns were about lack of medical attention,” Senator Padilla told me by phone after his visit. He compared the facility’s conditions to what he saw during a tour of migrant detention facilities at Guantanamo Bay last year, explaining that it can take “weeks or months” for a detainee to receive care, “even for matters that, in my mind, seem pretty urgent.”

    [ad_2]

    Oren Peleg

    Source link

  • Zak Williams Brings His Mental Health Mission to This A.I. Startup: Interview

    [ad_1]

    Driven by personal experience, Zak Williams is helping shape an A.I. platform designed to improve how mental illness is diagnosed and treated. Elizabeth Weinberg

    As ChatGPT moves to encompass the full scope of health care, others are taking a more nuanced approach. One is Headlamp Health, whose new intelligence platform, Lumos AI, aims to advance a research field that has long stalled for drug developers, clinical trial researchers and clinicians working to solve complex mental health challenges in even more complex patients.

    With an advisory board that includes investor, entrepreneur and mental health advocate Zak Williams—the son of the late actor Robin Williams—Headlamp officially launched Lumos on Jan. 7. The platform is designed as a coordinated set of agentic A.I. layers meant to bring precision medicine to a space that has long lacked it.

    “I never thought I’d go into the mental health space,” Williams told Observer. “But after my father died by suicide, and I was diagnosed with complex post-traumatic stress disorder, generalized anxiety disorder and depression, I found myself in need of solutions.”

    That experience led Williams to work with Headlamp Health, where he advises on both the technology and its market positioning. He saw not only a need for reinvention in psychiatry, but also an opportunity to help others where he could.

    Erwin Estigarribia, CEO of Headlamp Health, who previously focused on oncology and cardiology technology, has his own reasons for entering the psychiatry tech space. “I was exposed to the mental health side of medicine through family members and personal circumstances, and realized, holy smokes, the entire field is about 20 years behind cancer and cardiology,” Estigarribia told Observer.

    Bringing precision medicine to psychiatry

    Robin Williams suffered from the brain disease Lewy body dementia, a diagnosis discovered only through autopsy and later made public by his wife, Susan Schneider Williams. During his life, he sought treatment for what appeared—even to medical experts—to be unrelated symptoms, including tremors, delusions and high cortisol levels. Prior to his suicide, he was misdiagnosed with Parkinson’s disease. As many as half of the people with Lewy body dementia are misdiagnosed.

    The problem extends far beyond one illness. Schizoaffective disorder is misdiagnosed 75 percent of the time, while even the more common major depressive disorder is misdiagnosed in more than half of cases.

    As precision medicine becomes the standard in fields like oncology, psychiatry continues to lag behind. But multilayered A.I. systems are beginning to close the gap. Lumos AI has several core use cases: identifying patient subtypes most likely to benefit from a given therapy; making clinical trials more efficient and effective; de-risking drug development; and modeling how patients change over time.

    To power that work, Headlamp has compiled at least 100 million data points—both proprietary and from external health data sources, spanning decades of research. These are fed into layered A.I. frameworks designed to answer a central question: What is the right therapy for the right patient at the right time?

    Williams said much of recent A.I. in mental health has focused on automation, but Lumos is built differently. “It’s structured to help identify responder versus nonresponder populations way earlier in development,” he said. “Then, leveraging that longitudinal, real-world and behavioral data informs trial design and treatment matching.”

    With clinicians and researchers kept in the loop, decisions come from the “better organization of data, which then leads to better inference and better causal reasoning,” Williams said.

    Mental illness is largely episodic and invisible. “We can’t take a picture of depression [or] anxiety,” Estigarribia said. “Measuring it reliably in the blood is something that we’re not able to do due to the blood-brain barrier, which essentially isolates the organ of interest that we’re interested in studying.” Tools that better isolate and interpret the contributing factors behind psychiatric conditions could drive a sea change for millions of people simply trying to get through each day.

    Headlamp Health CEO Erwin Estigarribia in a navy blue jacketHeadlamp Health CEO Erwin Estigarribia in a navy blue jacket
    Headlamp Health CEO Erwin Estigarribia. Courtesey Headlamp Health

    Roughly 49,000 people in the U.S. died by suicide in 2024, according to provisional U.S. Census data. Research suggests an average of 135 people are significantly affected by each suicide death—people who may themselves need mental health support.

    In clinical settings, Estigarribia said Lumos AI’s suicide prevention impact was not the original goal, but has been a welcome outcome. “Being able to provide clinicians an A.I.-driven real-time view of their [patients] and highlight who is trending positive, negative or neutral since their last visit has actually led to several tragedies being averted.”

    On the research side, as federal funding shrinks for the National Institutes of Health and other agencies, platforms like Lumos can help researchers find efficiencies that keep essential studies moving forward. Beyond the statistics, those advances translate into real changes in individual lives.

    Improving life, not just delaying death

    Other companies are also using A.I. to streamline clinical trials, from patient-matching platforms like BEKHealth to decentralized trial tools such as Datacubed Health. Headlamp, however, is targeting a narrower and less-served niche: working directly with neuroscience researchers, psychiatric drug developers and frontline clinicians, with psychiatry as its sole focus rather than the broader life sciences.

    “Because we are the primary aggregator of all types of data, we want people to innovate on wearables, advanced imaging, blood biomarkers [and] cognitive therapies,” Estigarribia said. “We will collaborate, share data and work with anybody whose mission aligns with ours.” The key to tackling such large problems, he added, is to “stay humble, develop gratitude and be collaborative.”

    Using A.I. to process sensitive psychiatric health data for clinical decision support carries risks, especially around privacy. As Alexander Tsiaras, founder and CEO of the A.I.-driven medical records platform StoryMD, previously told Observer regarding ChatGPT Health, strong encryption is now an industry standard. The real question, he said, is, “Once you have the data, can you trust them?”

    For Williams, who is highly selective about his partnerships, Headlamp met his criteria, including in the area of trust. He evaluated the company and its technology by asking: “Are there good people involved with the organization? Do these people care deeply about how these outcomes are being delivered, how it’s improving the lives of folks, and is it contributing to the greater benefit of humanity?”

    Another concern is the integrity of the A.I. itself. Williams pointed to the risk of semantic collapse, in which systems fail as data volume overwhelms reasoning. “There’s a critical need to shift from data volume to data reasoning, to focus on actionable insight,” he said, adding that this is precisely what Headlamp aims to do with Lumos.

    Robin Williams, in his role as Patch Adams in the 1998 film about the real-life physician, once said, “Our job is improving the quality of life, not just delaying death.”

    Through Headlamp, Estigarribia and his team are trying to live up to that idea. “If I don’t feel safe enough for [Lumos] to be used by my own mother, then it’s not something that we can deploy,” he said.

    Zak Williams Brings His Mental Health Mission to This A.I. Startup: Interview

    [ad_2]

    Rachel Curry

    Source link

  • States go their own way as RFK Jr. shifts federal vaccine policy

    [ad_1]

    By Tim Henderson, Stateline.org

    New federal guidance to reduce the number of vaccines recommended for all children from 17 vaccines down to 11 comes as states already are charting their own courses on vaccine policy.

    [ad_2]

    Tribune News Service

    Source link

  • Obamacare enrollment dips in Bay Area after extra subsidy expires

    [ad_1]

    Enrollment in Obamacare is slowing down in California after Republicans in Congress opted not to extend a policy that beefed up financial assistance for patients, a move that led to the longest federal government shutdown in U.S. history.

    About 175,000 people statewide have newly enrolled in Covered California, the state’s Affordable Care Act marketplace, so far for 2026. That’s a 31% decrease from this time last year, data shows. Health experts expect bigger declines in the coming months, as more enrollees receive notice of price hikes and cancel their plans. Meanwhile, more people are opting for bronze-level plans with high deductibles and limited coverage.

    “These early numbers don’t even show the extent of what’s likely to happen as people have to pay their premium bills and find they can’t afford them with all their other household expenses,” said Larry Levitt, executive vice president for health policy at KFF.

    Bay Area counties are already clocking declines in new enrollees: 27% in Contra Costa County, 24% in Alameda County and 23% in Santa Clara County, according to Covered California’s data.

    Health officials and advocates gathered in downtown Oakland Tuesday to urge residents to sign up for a Covered California insurance plan before the Jan. 31 deadline, or see if they’re eligible.

    Jessica Altman, third from left, executive director of Covered California speaks with panel members after a press conference on Tuesday, Jan. 20, 2026, in Oakland, Calif. Officials held the press conference to talk about the open enrollment period for the state’s healthcare marketplace. (Aric Crabb/Bay Area News Group) 

    Even though the enhanced assistance expired at the end of 2025, spiking costs for many, Covered California plans are still more affordable than private insurance, they said. About half of Covered California enrollees are eligible for health plans that cost about $10 a month, and the vast majority qualify for reduced-price insurance, said the marketplace’s Executive Director Jessica Altman.

    “If you’re on the fence — get off the fence,” said Rose Wilkerson, a caregiver and Covered California enrollee who lives in Kensington near the Berkeley Hills. Wilkerson said she pays about $150 a month for a Covered California plan, the same cost as last year.

    That bucks the trend in California, after President Donald Trump and Republicans in Congress last year declined to extend tax credits used by millions nationwide to afford health insurance.

    Rose Wilkerson a self-employed health care worker talks about her use of Covered California on Tuesday, Jan. 20, 2026, in Oakland, Calif. Officials held a press conference to talk about the open enrollment period for the state's healthcare marketplace. (Aric Crabb/Bay Area News Group)
    Rose Wilkerson a self-employed health care worker talks about her use of Covered California on Tuesday, Jan. 20, 2026, in Oakland, Calif. Officials held a press conference to talk about the open enrollment period for the state’s healthcare marketplace. (Aric Crabb/Bay Area News Group) 

    With the extra help eliminated, the average Covered California plan doubled in cost for 2026, state officials said. The biggest increases were expected for middle-income households and adults in their 50s or 60s, close to Medicare eligibility, whose monthly premiums would rise from $186 to $365, officials said.

    Democrats passed the increased assistance during the height of the COVID-19 pandemic. When Republicans opted not to extend the tax credits in the fall, Democrats in the Senate withheld their votes from a budget agreement, kicking off the longest federal government shutdown in U.S. history. That strategy proved unsuccessful when a group of moderate Democrats broke ranks.

    Then, earlier this month, a group of Republicans, including Central Valley Rep. David Valadao, broke with their party’s leadership to pass a bill extending the subsidies. That move may ultimately be unsuccessful. The legislation was not included in a major health policy compromise announced Tuesday between Republicans and Democrats in Congress, Politico reported. Levitt, of KFF, said negotiations to extend the subsidies are now “hanging by a thread.”

    Rose Wilkerson a self-employed health care worker talks about her use of Covered California on Tuesday, Jan. 20, 2026, in Oakland, Calif. Officials held a press conference to talk about the open enrollment period for the state's healthcare marketplace. (Aric Crabb/Bay Area News Group)
    Rose Wilkerson a self-employed health care worker talks about her use of Covered California on Tuesday, Jan. 20, 2026, in Oakland, Calif. Officials held a press conference to talk about the open enrollment period for the state’s healthcare marketplace. (Aric Crabb/Bay Area News Group) 

    Health advocates in Oakland said they still hope politicians in Washington, D.C., revive the enhanced subsidies. If members of Congress did reach an agreement, Covered California would extend its enrollment period or reopen it, Altman said, so more patients could access financial assistance.

    “We’re hoping that someone, somewhere, can save the day,” said Njeri McGee-Tyner, director of healthcare access for the Alameda Health Consortium.

    In the meantime, McGee-Tyner said her organization’s health navigators are helping customers weigh their options if they’re priced out of the Covered California marketplace. Bigger monthly premiums for some families mean hard choices between medical care, rent and putting food on the table, she said.

    One such option? Paying for a bronze plan, she said. Many in California are taking that route. According to Covered California’s data, more than a third of new customers are enrolling in bronze plans, compared with one-fifth at this time last year, a spokesperson said.

    Customers who can’t afford even the lowest-level Covered California plans may lose their insurance. If their income drops, they may qualify for Medi-Cal, the state’s health plan for low-income residents that is also seeing cuts. Seniors may age into Medicare eligibility, and others will hunt for a job that offers health insurance. However, employer-sponsored health plans also rose in cost this year.

    [ad_2]

    Grant Stringer

    Source link

  • What Doctors Really Think of ChatGPT Health and A.I. Medical Advice

    [ad_1]

    The rush to deploy A.I. in health care raises hard questions about accuracy and trust. Unsplash

    Each week, more than 230 million people globally ask ChatGPT questions about health and wellness, according to OpenAI. Seeing a vast, untapped demand, OpenAI earlier this month launched ChatGPT Health and made a swift $60 million acquisition of the health care tech startup Torch to turbocharge the effort. Anthropic soon followed suit, announcing Claude for Healthcare last week. The move from general-purpose chatbot to health care advisor is well underway.

    For a world rife with health care inequities—whether skyrocketing insurance costs in the U.S. or care deserts in remote regions around the globe—democratized information and advice about one’s health is, at least in theory, a positive development. But the intricacies of how large A.I. companies operate raise questions that health tech experts are eager to interrogate.

    “What I am worried about as a clinician is that there is still a high level of hallucinations and erroneous information that sometimes makes it out of these general-purpose LLMs to the end user,” said Saurabh Gombar, a clinical instructor at Stanford Health Care and the chief medical officer and co-founder of Atropos Health, an A.I. clinical decision support platform.

    “It’s one thing if you’re asking for a spaghetti recipe and it’s telling you to add 10 times the amount [of an ingredient] that you should. But it’s a totally different thing if it’s fundamentally missing something about the health care of the individual,” he told Observer.

    For example, a doctor might see left shoulder pain as a non-traditional sign of a heart attack in certain patients, whereas a chatbot might only suggest taking an over-the-counter pain medication. The reverse can also happen. If a patient comes to a provider convinced they have a rare disorder based on a simple symptom after chatting with A.I., it can erode trust when a human doctor seeks to rule out more common explanations first.

    Google is already under fire for its AI Overviews providing inaccurate and false health information. ChatGPT, Claude and other chatbots have faced similar criticism for hallucinations and misinformation, even as they attempt to limit liability in health-related conversations by noting that they are “not intended for diagnosis or treatment.

    Gombar argues that A.I. companies must do more to publicly emphasize how often an answer may be hallucinated and clearly flag when information is poorly grounded in evidence or entirely fabricated. This is particularly important given that extensive chatbot disclaimers serve to prevent legal recourse, whereas human health care models allow individuals to sue for malpractice.

    The primary care provider workforce in the U.S. has shrunk by 11 percent annually over the past seven years, especially in rural areas. Gombar suggests that physicians may no longer control how they fit into the global health care landscape. “If the whole world is moving away from going to physicians first, then physicians are going to be utilized more as an expert second opinion, as opposed to the primary opinion,” he said.

    The inevitable question of data privacy

    OpenAI and Anthropic have been explicit that their health tools are secure and compliant, including with the Health Insurance Portability and Accountability Act (HIPAA) in the U.S., which protects sensitive patient health information from unauthorized use and disclosure. But for Alexander Tsiaras, founder and CEO of the A.I.-driven medical record platform StoryMD, there is more to consider.

    “It’s not the protection from being hacked. It’s the protection of what they will do with [the data] after,” Tsiaras told Observer. “In the back end, their encryption algorithms are as good as anyone in HIPAA. But once you have the data, can you trust them? And that’s where I think it’s going to be a real problem, because I certainly would not trust them.”

    Tsiaras points to the persistent techno-optimism of Silicon Valley elites like OpenAI CEO Sam Altman, arguing that they live in a bubble and have “proven themselves to not care.”

    On a more tangible level, chatbots tend to be overly agreeable. xAI’s Grok recently drew criticism for agreeing to generate nearly nude photos of real women and children, though the company blocked this capability this week following public outcry. Chatbots can also reinforce delusions and harmful thought patterns in people with mental illness, triggering crises such as psychosis or even suicide.

    Andrew Crawford, senior counsel for privacy and data at the nonpartisan think tank Center for Democracy and Technology, said an A.I. company prioritizing profit through personalization over data protection can put sensitive health information at serious risk.

    “Especially as OpenAI moves to explore advertising as a business model, it’s crucial that the separation between this sort of health data and memories that ChatGPT captures from other conversations is airtight,” Crawford said in a statement to Observer.

    Then there is the question of non-protected health data that users voluntarily input. Personal wellness companies such as MyFitnessPal and Oura already pose data privacy risks. “It’s amplifying the inherent risk by making that data more available and accessible,” Gombar said.

    For people like Tsiaras, profit-driven A.I. giants have tainted the health tech space. “The trust is eroded so significantly that anyone [else] who builds a system has to go in the opposite direction of spending a lot of time proving that we’re there for you and not about abusing what we can get from you,” he said.

    Nasim Afsar, a physician, former chief health officer at Oracle and advisor to the White House and global health agencies, views ChatGPT Health as an early step toward what she calls intelligent health, but far from a complete solution.

    “A.I. can now explain data and prepare patients for visits,” Afsar said in a statement to Observer. “That’s meaningful progress. But transformation happens when intelligence drives prevention, coordinated action and measurable health outcomes, not just better answers inside a broken system.”

    What Doctors Really Think of ChatGPT Health and A.I. Medical Advice

    [ad_2]

    Rachel Curry

    Source link

  • Trump Repackages Random Ideas Into ‘Great Healthcare Plan’

    [ad_1]

    Out of the blue.
    Photo: X/@WhiteHouse

    For many years, dating all the way back to 2015, Donald Trump has promised he’d someday offer a health-care plan to replace Obamacare. For months Republicans have fretted over allegations that they are clueless or heartless about rising health-care costs, exacerbated by their refusal to extend expiring Obamacare-premium subsidies received by around 22 million Americans. They’ve tossed out a bunch of random conservative health-care panaceas, as has Trump, mostly revolving around health savings accounts and other individualistic measures for undermining Obamacare-style regulated insurance markets.

    Today, without any warning, Trump released a video claiming a bunch of these well-worn ideas represent the “Great Healthcare Plan” he’s been talking about for so long.

    It’s significantly less vague than most of his past maunderings on health care but hardly anything you could call a blueprint, as the New York Times observed:

    The plan was short on specific details and left much of the direction for how to finalize it up to Congress. It amounted to a few paragraphs on a webpage, released with a video of Mr. Trump promoting what he called “the great health care plan.”

    Trump’s video unveiling this “proposal” was an odd pastiche of boasts about what he’s already done in the health-care arena (particularly his jawboning of pharmaceutical companies to lower prices for some drugs), denunciations of the “Unaffordable Care Act” (a term he clearly considers a bon mot), and wild claims about how incredibly good and cheap health care will soon become. He talked of lowering prices by far more than 100 percent, which is a mathematical impossibility. He failed even to mention the biggest problem Obamacare was created to address: the refusal of insurers to provide coverage for people with preexisting conditions or inherently expensive treatments. And once again, Trump’s impulses led him in contradictory directions; despite his denunciations of Obamacare, one of his big ideas is to build on an Obamacare discount feature called “cost-sharing reductions.”

    It’s unclear what Congress is expected to do with this plate of spaghetti thrown against the wall. Not a single Democrat will support this “plan,” which whatever it is, clearly aims to blow up Obamacare, just as Trump and the GOP unsuccessfully tried to do in 2017. That means the only path forward is via the party-line budget-reconciliation procedure, like the one that produced last year’s One Bill Beautiful Bill Act. Going in that direction in an election year with a topic as complex and controversial as health care may please conservative hard-liners who have been longing to destroy Obamacare for many years. But it hardly seems doable in a Congress where Republicans have such tiny margins of control.

    More likely than not, the president is just engaging in some high-visibility pre-midterm “messaging” to show concern over a set of problems that have stumped him and his party for eons. Maybe it will eventually turn into a proposal that more or less hangs together, even if its enactment by Congress is the longest stretch imaginable. Unfortunately, Trump’s claim that he has a “plan” will almost certainly kill off the already languishing efforts to come up with a bipartisan fix for the Obamacare-premium spike that is just now beginning to be felt in pocketbooks everywhere. He should have kept his rambling thoughts to himself.


    See All



    [ad_2]

    Ed Kilgore

    Source link